Physician profile
Vignessh Kumar
NPI 1649730359
$9,594.83
in general payments reported to CMS, 2019-2025
10 companies · $998 in 2025
The $998 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,976 · 2023: $2,902 · 2024: $3,718 · 2025: $998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,813 · Travel and Lodging: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,812.65 |
| Travel and Lodging | $805.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,175.70 | 2022-2024 | Serrato, Everest Spinal System, N/A |
| Globus Medical, INC. | $1,329.70 | 2023-2024 | Reline, Excelsiusgps Robotic Navigation System, Versatie |
| Nuvasive, INC. | $773.62 | 2023 | Xlif, Reline, Vuepoint |
| Medical Device Business Services, INC. | $772.56 | 2024-2025 | Teligen, Symphony |
| Vb Spine LLC | $611.64 | 2025 | Capri Corpectomy Cage System, Mesa Spinal System, Prolift |
| Si-Bone, INC. | $358.98 | 2023-2024 | |
| Kuros Biosciences USA, INC | $262.85 | 2025 | Magnetos |
| Depuy Synthes Sales INC. | $145.31 | 2024-2025 | Chronos, Matrixneuro, Synthecel |
| Integra Lifesciences Corporation | $134.31 | 2022 | |
| Elevation Spine, INC. | $30.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vignessh Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.